Skip to content

The Complex Cancer Care Coverage Environment — What is the Role of Legislation? A Case Study from Massachusetts

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Over the past decades, anti-cancer treatments have evolved rapidly from cytotoxic chemotherapies to targeted therapies including oral targeted medications and injectable immuno-oncology and cell therapies. New anti-cancer medications come to markets at increasingly high prices, and health insurance coverage is crucial for patient access to these therapies. State laws are intended to facilitate insurance coverage of anti-cancer therapies. Using Massachusetts as a case study, we identified five current cancer coverage state laws and interviewed experts on their perceptions of the relevance of the laws and how well they meet the current needs of cancer care given rapid changes in therapies. Interviewees emphasized that cancer therapies, as compared to many other therapeutic areas, are unique because insurance legislation targets their coverage. They identified the oral chemotherapy parity law as contributing to increasing treatment costs in commercial insurance. For commercial insurers, coverage mandates combined with the realities of new cancer medications — including high prices and often limited evidence of efficacy at approval — compound a difficult situation. Respondents recommended policy approaches to address this challenging coverage environment, including the implementation of closed formularies, the use of cost-effectiveness studies to guide coverage decisions, and the application of value-based pricing concepts. Given the evolution of cancer therapeutics, it may be time to evaluate the benefits and challenges of cancer coverage mandates.

Cite

CITATION STYLE

APA

Leopold, C., Haffajee, R. L., Lu, C. Y., & Wagner, A. K. (2020). The Complex Cancer Care Coverage Environment — What is the Role of Legislation? A Case Study from Massachusetts. Journal of Law, Medicine and Ethics, 48(3), 538–551. https://doi.org/10.1177/1073110520958879

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free